Author Correction: AHR is a Zika virus host factor and a candidate target for antiviral therapy

Federico Giovannoni; Irene Bosch; Carolina Manganeli Polonio; María F Torti; Michael A Wheeler; Zhaorong Li; Leonardo Romorini; María S Rodriguez Varela; Veit Rothhammer; Andreia Barroso; Emily C Tjon; Liliana M Sanmarco; Maisa C Takenaka; Seyed Mohamad Sadegh Modaresi; Cristina Gutiérrez-Vázquez; Nágela Ghabdan Zanluqui; Nilton Barreto Dos Santos; Carolina Demarchi Munhoz; Zhongyan Wang; Elsa B Damonte; David Sherr; Lee Gehrke; Jean Pierre Schatzmann Peron; Cybele C Garcia; Francisco J Quintana

doi:10.1038/s41593-020-0700-0

Author Correction: AHR is a Zika virus host factor and a candidate target for antiviral therapy

Nat Neurosci. 2020 Oct;23(10):1307. doi: 10.1038/s41593-020-0700-0.

Authors

Federico Giovannoni^{1

2}, Irene Bosch^{3

4}, Carolina Manganeli Polonio^{5

6}, María F Torti², Michael A Wheeler¹, Zhaorong Li¹, Leonardo Romorini⁷, María S Rodriguez Varela⁷, Veit Rothhammer¹, Andreia Barroso¹, Emily C Tjon¹, Liliana M Sanmarco¹, Maisa C Takenaka¹, Seyed Mohamad Sadegh Modaresi¹, Cristina Gutiérrez-Vázquez¹, Nágela Ghabdan Zanluqui^{6

8}, Nilton Barreto Dos Santos⁹, Carolina Demarchi Munhoz⁹, Zhongyan Wang¹⁰, Elsa B Damonte², David Sherr¹⁰, Lee Gehrke^{3

11}, Jean Pierre Schatzmann Peron^#^{12

13

14}, Cybele C Garcia^#¹⁵, Francisco J Quintana^#^{16

17}

Affiliations

¹ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina.
³ Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.
⁵ Neuroimmune Interactions Laboratory, Immunology Department-ICB IV, University of São Paulo, São Paulo, Brazil.
⁶ Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil.
⁷ Laboratorio de Investigación aplicada a Neurociencias, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Buenos Aires, Argentina.
⁸ Immunopathology and Allergy Post Graduate Program, School of Medicine, University of São Paulo, São Paulo, Brazil.
⁹ Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
¹⁰ Dept. of Environmental Health, Boston University School of Public Health, Boston, MA, USA.
¹¹ Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.
¹² Neuroimmune Interactions Laboratory, Immunology Department-ICB IV, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.
¹³ Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.
¹⁴ Immunopathology and Allergy Post Graduate Program, School of Medicine, University of São Paulo, São Paulo, Brazil. jeanpierre@usp.br.
¹⁵ Laboratorio de Estrategias Antivirales, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. CONICET-Instituto de Química Biológica, Buenos Aires, Argentina. cygarcia@qb.fcen.uba.ar.
¹⁶ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.
¹⁷ Broad Institute of MIT and Harvard, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.

^# Contributed equally.

PMID: 32778795
DOI: 10.1038/s41593-020-0700-0

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum